AGBL3 and rheumatoid arthritis: In the prospectively evaluated Healthfair cohort of anti-CCP3 positive subjects without IA at baseline, we have identified that baseline or incident dual positivity for RF-IgA and RF-IgM is indicative of a subset of individuals who have a greater likelihood of developing near-term incident IA/RA.